心臟穩定裝置市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、應用、最終用戶、地區和競爭對手分類，2021-2031年

全球脈動心臟穩定裝置市場預計將從 2025 年的 2.7878 億美元成長到 2031 年的 4.1324 億美元，複合年成長率為 6.78%。

這些專用外科器械旨在非體外迴圈冠狀動脈繞道手術移植術（CABG）中固定心肌的特定區域，使外科醫生能夠在無需心肺體外迴圈的情況下對跳動的心臟進行手術。市場擴張主要受心血管疾病盛行率上升的驅動。根據美國心臟協會預測，2025年，心血管疾病仍將是全球首要死因，每年約造成1,941萬人死亡。如此沉重的疾病負擔推動了對有效心臟重組工具的持續需求，同時，臨床上越來越傾向於選擇能夠減少體外循環相關併發症（如全身性發炎和中風）的手術方式，這也促進了市場成長。

然而，這些穩定器的廣泛應用面臨一個主要障礙：掌握非體外循環手術所需技能的困難。在跳動的心臟上進行吻合術需要高度專業化的訓練和卓越的手部靈巧性，這對於許多習慣於傳統體外循環手術的外科醫生來說是一個巨大的挑戰。這種猶豫阻礙了穩定器器在心臟外科手術中更廣泛的應用。

市場促進因素

全球搏動式心臟穩定器市場的主要驅動力是微創和機器人輔助手術需求的不斷成長。隨著外科手術方式向微創方向發展，人們越來越依賴先進的穩定系統，這些系統能夠在不停止心臟跳動的情況下，透過更小的切口和機器人端口實現精準的吻合。醫院對機器人平台的巨額投資進一步強化了這一趨勢，旨在改善患者預後並縮短復原時間，直接促進了相容穩定器的應用。例如，根據Intuitive Surgical在2025年1月發布的報告，2024年全球達文西手術量成長了約17%，凸顯了機器人生態系統的快速擴張，而高效能組織固定工具的需求也日益成長。

同時，全球心血管疾病盛行率的上升是推動市場成長的潛在因素，需要進行更多重組手術，維持了市場的發展動能。人口老化以及與肥胖等生活方式相關的風險因素，導致需要進行冠狀動脈繞道手術手術的患者群體不斷擴大，進而推動了一次性拋棄式產品的消費。根據世界心臟聯盟於2025年5月發布的《2025年世界心臟報告》，全球經年齡調整後，僅由高體重指數（BMI）導致的心血管疾病（CVD）死亡率為每10萬人22.8例。因此，主要行業參與者正受益於此需求，實現穩定的財務成長。 Getinge公司2024年的有機淨銷售額成長了4.9%，這主要得益於急診和心血管治療領域的持續訂單。

市場挑戰

非體外迴圈冠狀動脈繞道手術）固有的陡峭技能掌握曲線，顯著阻礙了全球搏動式心臟穩定裝置市場的成長。與傳統的心臟停搏手術不同，ON-PPT手術需要在搏動的心肌上進行精細的吻合，這要求極高的操作技巧和高度專業化的訓練。這種高要求構成了准入門檻，導致許多心臟外科醫生在轉向這項技術時猶豫不決，從而繼續依賴傳統的體外循環技術。

這種不願採用技術難度高的外科手術方式的現狀直接限制了醫療設備的採購。根據胸腔外科醫師協會預測，到2025年，非體外迴圈冠狀動脈繞道手術手術在美國所有血管重組手術中所佔比例將不足20%。只要手術的複雜性限制了其廣泛應用，對搏動式心臟穩定器的需求就將僅限於少數專業醫療機構，從而阻礙整體市場成長。

市場趨勢

一個關鍵的市場趨勢是混合重組的日益普及，它巧妙地結合了外科移植血管的耐久性和經皮介入治療的微創性。這種創新方法通常包括微創非體外循環下內乳動脈吻合術（通常需要高性能穩定器），隨後植入藥物釋放型支架。這種融合推動了對專用、超薄穩定器的需求，這些穩定器可以透過更小的切口進入手術，同時確保最佳的移植血管通暢性。Terumo Corporation心血管事業部2025會計年度的財務表現顯示，其銷售額成長了12.4%，這印證了上述趨勢。

同時，一次性穩定器系統正成為醫療產業的重要轉型方向，其主要驅動力在於降低手術部位感染率和提升整體營運效率。醫院正逐步以無菌一次性產品取代可重複使用的金屬器械，有效消除交叉感染風險，並減輕消毒的後勤負擔。對器械性能一致性的需求進一步加速了這一轉變。一次性產品顯著提升了Medtronic等公司心血管產品系列的銷售成長，因為它們能夠確保所有手術流程中器械的最佳機械性能，避免了可重複使用器械常見的性能衰減問題。在先進的手術解決方案和一次性產品的推動下，美敦力在2025會計年度第三季實現了5.0%的內部成長。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球心臟穩定裝置市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類型（真空穩定器、機械穩定器、其他）
  • 依應用領域（冠狀動脈繞道手術手術（CABG）、先天性心臟疾病手術、心房顫動手術等）
  • 依最終使用者（醫院/診所、門診中心、其他）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美心臟穩定裝置市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲心臟穩定器材市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區心臟穩定器市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲心臟穩定器材市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲心臟穩定器材市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球心臟穩定裝置市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Medtronic plc
• Terumo Corporation
• Getinge AB
• Abbott Laboratories, Inc.
• Boston Scientific Corporation
• LivaNova PLC
• Visionary Medtech Solutions Pvt. Ltd.
• HTKD Medical
• Beijing Medos AT Biotechnology
• Lepu Medical Technology Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Beating Heart Stabilizers Market is projected to grow from USD 278.78 million in 2025 to USD 413.24 million by 2031, demonstrating a compound annual growth rate of 6.78%. These specialized surgical devices are designed to immobilize specific sections of the myocardium during off-pump coronary artery bypass grafting (CABG), enabling surgeons to operate on a functioning heart without the need for cardiopulmonary bypass. The market's expansion is significantly supported by the rising prevalence of cardiovascular diseases, which according to the American Heart Association, remained the leading global cause of mortality in 2025, accounting for approximately 19.41 million deaths annually. This substantial disease burden drives consistent demand for effective cardiac revascularization tools, alongside a growing clinical preference for procedures that mitigate pump-associated complications such as systemic inflammation and stroke.

However, the widespread adoption of these stabilizers faces a notable impediment due to the steep technical learning curve associated with off-pump techniques. Performing anastomosis on a beating heart requires highly specialized training and exceptional dexterity, which can deter many surgeons accustomed to conventional on-pump methods. This hesitation limits the broader utilization of stabilizer devices within cardiac surgery.

Market Driver

A primary catalyst propelling the global beating heart stabilizers market is the accelerating demand for minimally invasive and robotic-assisted surgeries. As surgical paradigms increasingly shift towards less traumatic interventions, there is a heightened reliance on advanced stabilization systems that facilitate precise anastomosis through smaller incisions or robotic ports without arresting the heart. This trend is amplified by significant hospital investments in robotic platforms to improve patient outcomes and reduce recovery times, directly increasing the uptake of compatible stabilization devices. For instance, worldwide da Vinci procedures grew approximately 17% in 2024, as reported by Intuitive Surgical in January 2025, underscoring the rapid expansion of robotic ecosystems that require high-performance tissue stabilization tools.

Concurrently, the rising global prevalence of cardiovascular diseases serves as a fundamental driver, necessitating a greater volume of revascularization interventions and sustaining market momentum. The combined effects of an aging population and lifestyle-related risk factors, such as obesity, are expanding the patient pool requiring coronary artery bypass grafting, thereby driving the consumption of stabilizing disposables. The World Heart Federation's May 2025 'World Heart Report 2025' indicated that the global age-standardized CVD mortality rate attributable to high body mass index alone stood at 22.8 deaths per 100,000 people. Consequently, major industry players are experiencing tangible financial growth linked to this demand, with Getinge achieving an organic net sales increase of 4.9% in 2024, significantly driven by sustained order intake for acute care and cardiovascular therapies.

Market Challenge

The steep technical learning curve inherent in off-pump coronary artery bypass grafting significantly impedes the expansion of the global beating heart stabilizers market. Unlike conventional procedures that involve arresting the heart, off-pump surgery mandates performing delicate anastomosis on a moving myocardium, which requires exceptional manual dexterity and highly specialized training. This demanding requirement creates a substantial barrier to entry, deterring a large proportion of cardiac surgeons from transitioning to this method and consequently leading to a continued reliance on traditional on-pump techniques.

This reluctance to adopt technically challenging procedures directly suppresses the volume of device procurement. According to the Society of Thoracic Surgeons, off-pump coronary artery bypass grafting accounted for fewer than 20% of all surgical revascularization procedures performed in the United States in 2025. As long as procedural complexity limits widespread surgical adoption, the demand for beating heart stabilizers will remain constrained to a niche segment of specialized centers, thereby hindering broader market growth.

Market Trends

A significant market trend involves the increasing implementation of hybrid revascularization procedures, which skillfully merge the durability of surgical grafting with the reduced invasiveness of percutaneous interventions. This innovative approach typically incorporates a minimally invasive off-pump internal mammary artery anastomosis, which critically requires high-performance stabilizers, followed by drug-eluting stent implantation. This convergence drives a heightened demand for specialized, low-profile stabilization devices that facilitate access through smaller incisions while simultaneously ensuring optimal graft patency, as evidenced by Terumo Corporation's Cardiac and Vascular Company segment recording a 12.4% revenue increase in their Fiscal Year 2025 results.

Concurrently, there is a decisive transition towards single-use and disposable stabilizer systems, primarily driven by the imperative to mitigate surgical site infections and enhance overall operational efficiency. Hospitals are increasingly opting to replace reusable metal devices with sterile, single-use alternatives, effectively eliminating risks associated with cross-contamination and reducing the logistical burden of sterilization. This shift is further accelerated by the need for consistent device performance, as disposable units guarantee optimal mechanical function for every procedure without the degradation often observed in reusable instruments, significantly contributing to the cardiovascular portfolio revenue growth for companies like Medtronic, which saw a 5.0% organic increase in Q3 Fiscal 2025, largely from advanced procedural solutions and disposables.

Key Market Players

• Medtronic plc
• Terumo Corporation
• Getinge AB
• Abbott Laboratories, Inc.
• Boston Scientific Corporation
• LivaNova PLC
• Visionary Medtech Solutions Pvt. Ltd.
• HTKD Medical
• Beijing Medos AT Biotechnology
• Lepu Medical Technology Co., Ltd.

Report Scope

In this report, the Global Beating Heart Stabilizers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Beating Heart Stabilizers Market, By Product Type

• Vacuum based Stabilizers
• Mechanical Stabilizers
• Others

Beating Heart Stabilizers Market, By Application

• Coronary Artery Bypass (CABG)
• Congenital Heart Defect Surgeries
• Atrial fibrillation surgery
• Others

Beating Heart Stabilizers Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centres
• Others

Beating Heart Stabilizers Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Beating Heart Stabilizers Market.

Available Customizations:

Global Beating Heart Stabilizers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Beating Heart Stabilizers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Vacuum based Stabilizers, Mechanical Stabilizers, Others)
  • 5.2.2. By Application (Coronary Artery Bypass (CABG), Congenital Heart Defect Surgeries, Atrial fibrillation surgery, Others)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centres, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Beating Heart Stabilizers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Beating Heart Stabilizers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Beating Heart Stabilizers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Beating Heart Stabilizers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Beating Heart Stabilizers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Beating Heart Stabilizers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Beating Heart Stabilizers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Beating Heart Stabilizers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Beating Heart Stabilizers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Beating Heart Stabilizers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Beating Heart Stabilizers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Beating Heart Stabilizers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Beating Heart Stabilizers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Beating Heart Stabilizers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Beating Heart Stabilizers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Beating Heart Stabilizers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Beating Heart Stabilizers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Beating Heart Stabilizers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Beating Heart Stabilizers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Beating Heart Stabilizers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Beating Heart Stabilizers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Beating Heart Stabilizers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Beating Heart Stabilizers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Beating Heart Stabilizers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Beating Heart Stabilizers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Terumo Corporation
• 15.3. Getinge AB
• 15.4. Abbott Laboratories, Inc.
• 15.5. Boston Scientific Corporation
• 15.6. LivaNova PLC
• 15.7. Visionary Medtech Solutions Pvt. Ltd.
• 15.8. HTKD Medical
• 15.9. Beijing Medos AT Biotechnology
• 15.10. Lepu Medical Technology Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer